Diabetes & Metabolism Journal
Indexed in SCIE, Medline
- The incidence rate of CKD was over 4%/year among our Iranian diabetic population. - Older age, history of CVD, and lower levels of eGFR were significant risk factors. - Using glucose-lowering drugs and hypertension increased risk in CKD-EPI analysis. - Female sex and FPG level ≥10 mmol/L were also independent risk factors in MDRD. - CKD-EPI had higher discriminatory ability for prediction of CKD than MDRD.
-Nonalcoholic fatty liver disease (NAFLD) and albuminuria are associated with the aggravation of coexisting metabolic diseases. -Of total 100 patients with both type 2 diabetes (T2DM) and NAFLD, but without chronic kidney disease were recruited. -T2DM patients with significant hepatic steatosis had a higher prevalence of albuminuria. -Albuminuria showed a correlation with hepatic fatty burden, and was independently associated with significant hepatic steatosis.
-Most guidelines advocated lower official BP targets (-Inconsistency was observed among guidelines on the official BP thresholds for pharmacologic therapy in diabetes. -Hardly any of the guidelines provided relevant recommendations on the lower limit of official BP targets in diabetes. -Current guidelines lacked recommendations on ABPM/HBPM management in diabetes.
[1] 2 3 4